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Abstract
Background
Young Southern African women have the highest HIV incidence globally. Pregnancy dou-
bles the risk of HIV acquisition further, and maternal HIV acquisition contributes significantly
to the paediatric HIV burden. Little data on combination HIV prevention interventions during
pregnancy and lactation are available. We measured HIV incidence amongst pregnant and
postpartum women receiving a community-based combination HIV prevention intervention
in a high HIV incidence setting in South Africa.
Methods
A cohort study that included HIV-uninfected pregnant women was performed. Lay commu-
nity-based workers provided individualized HIV prevention counselling and performed
three-monthly home and clinic-based individual and couples HIV testing. Male partners
were referred for circumcision, sexually transmitted infections or HIV treatment as appropri-
ate. Kaplan-Meier analyses and Cox’s regression were used to estimate HIV incidence and
factors associated with HIV acquisition.
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Results
The 1356 women included (median age 22.5 years) received 5289 HIV tests. Eleven new
HIV infections were detected over 828.3 person-years (PY) of follow-up, with an HIV inci-
dence rate of 1.33 infections/100 PY (95% CI: 0.74–2.40). Antenatally, the HIV incidence
rate was 1.49 infections/100 PY (95% CI: 0.64–2.93) and postnatally the HIV incidence rate
was 1.03 infections/100 PY (95% CI: 0.33–3.19). 53% of male partners received HIV testing
and 66% of eligible partners received referral for circumcision. Women within known sero-
discordant couples, and women with newly diagnosed HIV-infected partners, adjusted haz-
ard ratio (aHR) = 32.7 (95% CI: 3.8–282.2) and aHR = 126.4 (95% CI: 33.8–472.2) had
substantially increased HIV acquisition, respectively. Women with circumcised partners had
a reduced risk of incident HIV infection, aHR = 0.22 (95% CI: 0.03–1.86).
Conclusions
Maternal HIV incidence was substantially lower than previous regional studies. Community-
based combination HIV prevention interventions may reduce high maternal HIV incidence in
resource-poor settings. Expanded roll-out of home-based couples HIV testing and initiating
pre-exposure prophylaxis for pregnant women within serodiscordant couples is needed in
Southern Africa.
Background
Southern Africa is the epicentre of the HIV pandemic having the highest burden of HIV glob-
ally [1]. Young women and adolescent girls are the demographic group having the highest
HIV incidence, up to eight-fold higher than their male peers, attributed to complex social,
behavioural, biologic and structural factors [2–4].
HIV acquisition is further increased two to four-fold during pregnancy, due to biological
and behavioural factors including immunological changes, hormonal changes affecting the
genital tract mucosa, higher frequency of unprotected sex and incident sexually transmitted
infections (STIs) during pregnancy [5–9]. HIV incidence remains increased during the post-
natal period [10,11]. In addition, mother-to-child transmission (MTCT) amongst women who
acquire HIV during pregnancy/lactation is double to triple compared to women who acquire
HIV prior to pregnancy [11,12], and contributes significantly to the Southern African pediatric
HIV burden [13,14].
HIV prevention in young women in sub-Saharan Africa is a public health imperative [15],
and prevention efforts during pregnancy and postpartum should be particularly prioritized
due to the increased risk of HIV acquisition in both women and infants [10,11]. Prevention
efforts have included structural, biomedical and behavioural interventions [16]. Behavioural
interventions have reported modest impact on self-reported HIV-preventive behaviours but
little impact on HIV incidence [3,17]. Biomedical prevention for pregnant and breastfeeding
women in South Africa is limited due to oral pre-exposure prophylaxis (PrEP) being contrain-
dicated in current guidelines because of limited safety data regarding the developing fetus and
infant [18,19], despite the World Health Organization’s (WHO) guidelines indicating that
PrEP “can be used during pregnancy” [20]. As HIV epidemics are complex due to a variety of
contextual risk factors, programs that incorporate comprehensive combination interventions
are important [3,4].
A community-based combination HIV prevention intervention for pregnant and postpartum women in South Africa
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Health systems interventions involving community-based workers have become increas-
ingly important in sub-Saharan Africa due to severe professional health worker shortages and
the WHOs recommendations regarding task-shifting [21,22]. Lay health worker interventions
have shown successes in HIV treatment programs [23,24], and the South African Department
of Health’s strategy to re-engineer primary healthcare emphasizes the critical role of commu-
nity health workers [25].
An important current knowledge gap is the lack of data regarding the effectiveness of com-
bination HIV prevention interventions during pregnancy and postpartum [4,26]. Evaluating
community-level interventions for maternal and neonatal health is also a current research pri-
ority [27].
A combination HIV prevention intervention for pregnant and postpartum women utilizing
community-based health workers has recently been established in KwaZulu-Natal province,
South Africa, a region having high HIV incidence [6,28]. This study aimed to measure this
interventions effectiveness in preventing incident HIV infection in this vulnerable key popula-
tion, and to investigate factors associated with HIV acquisition, and were aims that were
achieved.
Methods
Study design, setting and inclusion criteria
A cohort study utilizing enhanced routine clinical data was performed at an urban primary
healthcare facility north of Durban in eThekwini district. The district antenatal HIV preva-
lence in 2013 was 41.1% having increased from 38.0% in 2011 [29], with HIV incidence in
nonpregnant women being 6.4 infections/100 person-years (PY) [28].
All pregnant women who presented for antenatal care between 01 March 2013 and 31 May
2015 who tested HIV-negative at the first antenatal visit, who gave informed consent to enrol
in the community-based program, and who had one or more follow-up HIV tests at least 8
weeks after the initial HIV test were included in analyses. Women were followed-up with their
infants until the earliest of 18 months postpartum, transfer to another clinic, loss to follow-up
(LTFU), mortality, or 28 February 2016. For HIV-infected pregnant and breastfeeding
women, national guidelines recommended WHO option B (immediate triple ART until the
end of breastfeeding or lifelong if CD4 cell count < 350 cells/μL) prior to January 2015 [30],
and lifelong ART irrespective of CD4 cell count thereafter [31].
Community-based combination HIV prevention intervention
The intervention aimed to reduce HIV incidence in pregnancy and postpartum, thus to reduce
the number of infants being HIV-exposed. Behavioural and psychosocial component interven-
tions included individual counselling and education for women and their male household
partners regarding HIV risk and safe sex practices (including promotion of condom use), edu-
cation regarding multiple and concurrent sexual partnerships, couples counselling, counselling
regarding HIV serodiscordant couples, addressing alcohol and substance abuse, assessing and
addressing mental health needs, and group HIV prevention education at the clinic. Biomedical
interventions involved provision of male and female condoms, home and clinic-based three-
monthly individual and couples HIV testing and counselling (HTC) by community workers
throughout pregnancy until 18 months postpartum, facilitated linkage to HIV care facilities
for either partner testing HIV positive with subsequent antiretroviral treatment (ART) adher-
ence counselling, referral of eligible men for voluntary male medical circumcision (VMMC),
and symptom screening of women and male partners for sexually transmitted infections
(STIs) with referral for treatment if symptomatic. A structural component of the intervention
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involved assessment and counselling and referral for gender-based violence as required, and
discussion regarding gender identities and roles.
All women were assigned a community-based healthcare worker, named a Patient Advo-
cate (PA), who provided home and clinic-based support two to three-weekly until six weeks
postpartum, and monthly thereafter. PAs also provided education regarding contraception
and reproductive health, infant health and feeding practices, encouraged women to attend all
antenatal and infant immunization clinic visits, and supported women to access government
social security grants. Non-household male partners were invited to receive HTC at the facility
through word of mouth messages, invitation cards and telephonic invitations, but were not
physically traced to their homes.
Disclosure of HIV serostatus was addressed by PAs at enrolment and during HIV test coun-
selling. HIV test results were kept confidential by PAs (including in the case of minors with
regards to caregivers). PAs discussed possible disclosure of positive HIV status of participants
to others (including partners and caregivers); however, the decision whether to disclose HIV
status resided with the participant. An anonymized key was used to identify study participants
for data analyses.
The intervention was instituted by Kheth’Impilo, a nonprofit organization supporting the
Department of Health with public health systems innovations. PAs originally provided com-
munity-based adherence support to ART patients [24,32], and have more recently been uti-
lized for HIV prevention.
Outcomes and definitions
The primary outcome was the HIV incidence rate and cumulative HIV incidence amongst
HIV-uninfected pregnant and postpartum women. Secondary outcomes (other program effec-
tiveness and process measures) were: I) HIV incidence during pregnancy; II) Postpartum HIV
incidence (until 18 months); III) Socio-demographic factors associated with incident HIV
infection; IV) MTCT at 6 weeks postpartum amongst women with incident HIV infection
prior to 6 weeks postpartum (proportion of HIV-tested infants testing HIV positive); V) Time
from diagnosis until ART initiation amongst women with incident HIV; VI) Proportion of
women with incident antenatal HIV infection who initiated ART antenatally; VII) Maternal
mortality rate; VIII) Cumulative probability of LTFU of enrolled women; IX) Socio-demo-
graphic factors associated with LTFU; X) Proportion of male partners who received HTC
(with recorded test results); XI) Proportion of partners testing HIV positive successfully linked
with HIV care facilities; XII) Time from HIV diagnosis till ART initiation amongst partners
eligible to initiate ART; XIII) Proportion of eligible partners referred for VMMC.
Adult HIV testing was performed using the Advanced Quality(TM) Rapid Anti-HIV (1&2)
test, and positive tests were confirmed with the Abon(TM) HIV 1/2/O Tri-line Rapid test
device. Infant HIV testing was performed with HIV deoxyribosenucleic acid polymerase chain
reaction (PCR) testing. Maternal deaths were recorded as per professional healthcare worker
or PA report and defined as deaths during pregnancy or until 42 days of termination of preg-
nancy related to or aggravated by the pregnancy. LTFU was defined as no contact with clinic
staff or PA for at least 120 days from last recorded visit, or if reported as LTFU by the PA. Men
eligible to be referred for VMMC were uncircumcised males (by self-report) or who had
unknown circumcision status who tested HIV negative or who had unknown HIV status.
Data collection and statistical analyses
Enhanced routine clinical data were prospectively collected by site-based data capturers from
clinical records in a custom-designed electronic database following participant clinic visits.
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PAs collected home visit data with paper forms. Data accuracy were reviewed by the district
data co-ordinator and data queries resolved by site and community-based staff.
For HIV incidence, person-time was calculated from the first negative HIV test to the last
negative HIV test or the midpoint of the first positive test and the preceding negative test for
those who tested positive [33]. Person-time was also calculated using the first positive HIV test
date for those who tested positive; results were only insignificantly changed and results are pre-
sented using the midpoint as the time of infection. Participants transferring to other facilities
were censored at the last visit date. Cumulative HIV incidence and the cumulative probability
of LTFU were estimated using Kaplan-Meier analyses, and the logrank test used to compare
exposure categories. Cox’s proportional hazards regression was used to estimate univariable
and multivariable hazard ratios (HR) for associations of exposures with incident HIV infection
and LTFU. Variables associated with the outcomes were included in multivariable models
where their P-value in univariable models were 0.1. The Efron method was used to approxi-
mate the exact conditional probability of tied failure times [34]. Proportional hazards assump-
tions were assessed by comparing Kaplan-Meier observed survival curves and Cox predicted
curves for each variable, and statistical testing for nonzero slope of scaled Schoenfeld residuals
on functions of time. Model overall goodness-of-fit was assessed by plotting Cox-Snell residu-
als vs. the Nelson-Aalen cumulative hazard estimator. Data were analysed with Stata version
13.1 (College Station, TX, USA)(TM). The University of Cape Town Human Research Ethics
Committee granted ethical approval for the study.
Results
3480 pregnant women presented for antenatal care during the enrolment period. The follow-
ing were excluded (S1 Fig): 1583 women known or found to be HIV-infected at the first ante-
natal visit; 135 who declined consent to participate in the program; 329 who received no
follow-up HIV tests (short-term visitors to the area who transferred-out of the program); and
77 whose final HIV test result was < 8 weeks after the initial test. Thus, 1356 women were
included in analyses.
At baseline, the median age was 22.5 years (IQR: 19.4–27.0 years) and 30% were adolescents
(aged 19 years) (Table 1). The median gestational age at presentation was 16 weeks (IQR:
12–16 weeks). Almost two-thirds of women requested contraception counselling; 70%
required support to access government grants, and 7% requested counselling regarding gen-
der-based violence.
HIV incidence
Included women received 5289 HIV tests with a median of 4 HIV tests per woman. During
828.3 person-years of follow up, 11 new HIV infections were detected, yielding an HIV inci-
dence rate of 1.33 infections/100 PY (95% CI: 0.74–2.40). Cumulative HIV incidence after 12
months of follow-up was 0.92% (95% CI: 0.51%-1.66%).
Antenatally (i.e. between the first negative antenatal HIV test and delivery), eight new HIV
infections were detected during 537 person-years of follow-up, with an antenatal HIV inci-
dence rate of 1.49 infections/100 PY (95% CI: 0.64 to 2.93) and cumulative HIV incidence dur-
ing pregnancy of 0.68% (95% CI: 0.29%-1.33%). Postnatally, three new cases of HIV were
detected over 291 person-years, with an incidence rate of 1.03 infections/100 PY (95% CI:
0.33–3.19).
Table 1 shows HIV incidence according to socio-demographic characteristics of women
and their partners. Women with known HIV-infected partners at enrolment had an HIV inci-
dence rate of 40.3 infections/100 PY (95% CI: 5.67–286.0). Women whose partners had newly
A community-based combination HIV prevention intervention for pregnant and postpartum women in South Africa
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diagnosed HIV infection had very high HIV incidence, being 221.4 infections/100 PY (95%
CI: 83.1–590) with a cumulative probability of acquiring HIV twelve months after the first visit
of 80.0% (95% CI: 41.8%-99.1%) (Fig 1A). In contrast, women whose partners were HIV-unin-
fected or who had unknown HIV serostatus had an incidence rate of 0.73 infections/100 PY
(95% CI: 0.33–1.62) and a cumulative probability of acquiring HIV of 0.8% (95% CI: 0.3%-
1.8%) twelve months after the first visit (logrank P <0.0001). Amongst women with incident
HIV infection (n = 11), 45.5% had HIV-infected male partners and the remaining partners
had unknown HIV serostatus.
HIV incidence in women was higher where the male partner was uncircumcised (2.30
infections/100 PY [95% CI: 1.10–4.83] vs. 0.25 infections/100 PY [95 CI: 0.04–1.80] where
male partner circumcised; P = 0.011) (Fig 1B).
Table 2 shows univariable and multivariable analyses of factors associated with incident
HIV infection (n = 1356). Women with known HIV-infected male partners, adjusted hazard
ratio (aHR) = 32.7 (95% CI: 3.8–282.2), and women whose partners were newly diagnosed
with HIV infection, aHR = 126.4 (95% CI: 33.8–472.2) had substantially increased HIV
Table 1. Baseline characteristics and HIV incidence according to characteristics of pregnant women and their partners in South Africa.
Total, N (%) Infections/ 100 PY Incidence rate per 100 PY (95% CI) P-value*
Overall 1356 (100.0) 11/828.3 1.33 (0.74–2.40) -
Age at baseline 0.0303$
14–19 years 410 (30.2) 0/248.9 0 (0–1.48)
20–24 years 488 (36.0) 5/305.4 1.63 (0.68–3.93)
 25 years 458 (33.8) 6/273.9 2.19 (0.98–4.88)
Gestational age at first visit
< 14 weeks 427 (31.5) 4/278.2 1.44 (0.54–3.83) 0.853
14–27 weeks 882 (65.0) 7/526.1 1.33 (0.63–2.78)
 28 weeks 47 (3.5) 0/24.0 0 (0–15.3)
Requested contraception counselling? 0.72
Yes 892 (65.8) 9/631.7 1.42 (0.74–2.73)
No 464 (34.2) 2/196.5 1.01 (0.25–4.06)
Support to access social security grant 0.748
Support given 954 (70.4) 9/693.7 1.30 (0.67–2.49)
Support not given 402 (29.7) 2/134.5 1.49 (0.37–5.94)
Required gender-based violence counselling or referral 0.368
No 1264 (93.2) 11/769.5 1.43 (0.79–2.58)
Yes 92 (6.8) 0/58.7 0 (0–6.2)
Initial circumcision status of partner 0.011
circumcised 625 (46.1) 1/393.0 0.25 (0.04–1.80)
not circumcised 484 (35.7) 7/303.9 2.30 (1.10–4.83)
not recorded 247 (18.2) 3/131.4 2.28 (0.73–7.07)
Partners HIV status <0.0001
HIV uninfected 717 (52.9) 0/544.1 0 (0–0.7)
Known HIV infected at enrolment 4 (0.3) 1/2.48 40.3 (5.67–286.0)
Newly diagnosed HIV-infected 5 (0.4) 4/1.81 221.4 (83.1–590)
not HIV tested/unknown status 630 (46.5) 6/279.9 2.1 (0.96–4.77)
*P-values estimated by the log-rank test comparing HIV incidence.
$log-rank test for trend.
PY-person years.
https://doi.org/10.1371/journal.pone.0181691.t001
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Fig 1. Kaplan-Meier failure estimates of time till HIV infection amongst HIV-negative pregnant women. A) According to male partner’s HIV
serostatus, B) According to male partner’s circumcision status.
https://doi.org/10.1371/journal.pone.0181691.g001
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acquisition. Women with circumcised partners at baseline had a reduced risk of incident HIV
infection, although this did not reach statistical significance at the 95% level in the multivari-
able model, aHR = 0.22 (95% CI: 0.03–1.86).
Secondary outcomes
Table 3 lists the secondary study outcomes. Women with incident HIV infection initiated
ART on the same day as HIV diagnosis in most cases, and all women with antenatal incident
HIV infection initiated ART antenatally. Amongst women with incident HIV infection,
MTCT at 6 weeks postpartum was 22.2%.
One (0.07%) maternal death was recorded, with a maternal mortality rate of 0.12 deaths/
100 PY (95% CI: 0.02 to 0.85). During the study period, 122 (9.0%) women become LTFU. The
cumulative probability of LTFU twelve months after the first antenatal visit was 10.8% (95%
CI: 9.1%-12.8%). Table 4 shows the multivariable model of factors associated with LTFU
(n = 1356; 122 events). Women who first attended antenatal facilities in late pregnancy and
women aged 25 years had increased risks of LTFU. Women who received support to access
social security grants, women whose partners received HTC, and women who received family
planning counselling had reduced LTFU.
Amongst male partners, 722 (53.4%) received HTC and had a recorded HIV test result, of
whom 60.0% received home-based HTC. Five (0.7%) partners were newly diagnosed with HIV
infection. Amongst those women who acquired HIV and who had male partners with newly
diagnosed HIV infection (n = 4), all the partners first accepted HTC only after the women
tested HIV-positive (median 4.5 days). All the newly diagnosed HIV-infected male partners
were successfully linked with HIV care facilities; however, only 1/5 (20%) initiated ART (seven
days after HIV diagnosis), as the remainder had CD4 cell counts greater than 500 cells/μL and
were not eligible to initiate ART according to prevailing South African ART guidelines.
Amongst partners with recorded HIV serostatus and recorded baseline circumcision status,
HIV prevalence was considerably higher in uncircumcised males (3.3%) vs. 0.0% in
Table 2. Univariable and multivariable Cox regression of factors associated with incident maternal HIV infection (n = 1356).
Univariable Hazard
Ratio (HR)
Univariable 95% CI
for HR
P Multivariable
HR
95% CI for
multivariable HR
P
Age at baseline
< 25 years 1.0 (Ref) -
 25 years 2.42 0.73–7.94 0.14 -
Gestational age at first visit
< 14 weeks 1.0 (Ref) -
 14 weeks 0.92 0.26–3.15 0.90 -
Required contraception
counselling
1.32 0.28–6.21 0.73 -
Received support to access social
security grant
0.77 0.15–3.79 0.75 -
Male partner’s initial circumcision
status
not circumcised or unknown 1.0 (Ref) - 1.0 (Ref) -
circumcised 0.11 0.01–0.86 0.035 0.22 0.03–1.86 0.16
Male Partner’s HIV status
uninfected or not tested 1.0 (Ref) - 1.0 (Ref) -
known HIV-infected 52.4 6.3–438.3 <0.0001 32.7 3.8–282.2 0.001
newly diagnosed HIV infection 202.3 56.9–719.0 <0.0001 126.4 33.8–472.2 <0.0001
https://doi.org/10.1371/journal.pone.0181691.t002
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Table 3. Secondary study outcomes evaluating a combination HIV prevention intervention amongst pregnant and postpartum women in South
Africa.
Point estimate 95% Confidence interval (or
IQR)
Antenatal HIV incidence, infections/100 person-years 1.48 0.64 to 2.92
Postnatal HIV incidence, infections/100 person-years 1.03 0.33 to 3.19
Vertical HIV transmission amongst infants (at age six weeks) amongst women with incidence
HIV infection, n/N (%)
2/9* (22.2%) 2.8% to 60%
Time since diagnosis until initiating ART amongst women with incident HIV infection, days 0 IQR: 0–0
Proportion of women with incident antenatal HIV infection who initiated ART antenatally, n/N
(%)
8/8 (100%) 63.1% to 100%
Maternal mortality rate, deaths/person-years (deaths/100 person-years) & # 1/832.7 (0.12) 0.02 to 0.85
Cumulative probability of loss to follow-up 12 months after the first antenatal visit, %# 10.8% 9.1% to 12.8%
Proportion of eligible male partners received HTC with recorded test results, n/N (%) 722/1352
(53.4%)
50.7% to 56.1%
Proportion of male partners who received HTC with newly diagnosed HIV infection, n/N (%) 5/722 (0.7%) 0.2% to 1.6%
Proportion of newly diagnosed HIV-infected male partners linked to HIV care facilities, n/N (%) 5/5 (100%) 47.8% to 100.0%
Time from HIV diagnosis till ART initiation amongst males partners eligible to initiate ART, days 7 -
Proportion of eligible male partners referred for VMMC, n/N (%)** 476/722
(65.9%)
68.9% to 76.1%
* Two women tested HIV positive more than six weeks after birth, thus their infants did not receive HIV testing at the six week immunization visit.
# From Kaplan-Meier analyses.
** Eligible males were uncircumcised males (or who had unknown circumcision status) who tested HIV negative or who had unknown HIV status.
& Deaths during pregnancy or until 42 days of termination of pregnancy related to or aggravated by the pregnancy
ART-antiretroviral treatment; IQR-interquartile range; VMMC-voluntary male medical circumcision; HTC-HIV testing and counselling.
https://doi.org/10.1371/journal.pone.0181691.t003
Table 4. Factors associated with loss to follow-up amongst pregnant and postpartum women enrolled in a combination HIV prevention interven-
tion in South Africa.
Univariable Hazard
Ratio (HR)
Univariable 95% CI
for HR
P Multivariable
HR
95% CI for
multivariable HR
P
Age at baseline
< 20 years 1.0 (Ref) - 1.0 (Ref) -
20–24 years 1.11 0.69–1.78 0.66 1.08 0.67–1.73 0.75
 25 years 1.58 1.00–2.47 0.047 1.57 1.00–2.47 0.048
Gestational age at first visit
< 14 weeks 1.0 (Ref) - 1.0 (Ref) -
14–27 weeks 1.14 0.77–1.69 0.50 1.63 1.07–2.42 0.015
 28 weeks 1.99 0.83–4.71 0.10 3.63 1.52–8.70 0.004
Required gender-based violence
counselling or referral
1.64 0.93–2.92 0.090 1.52 0.78–2.96 0.21
Received contraception counselling 0.22 0.16–0.32 <0.001 0.58 0.35–0.97 0.036
Received support to access social
security grant
0.14 0.09–0.20 <0.001 0.31 0.18–0.53 <0.001
Male partner received HTC
No 1.0 (Ref) - 1.0 (Ref) -
Yes 0.16 0.10–0.24 <0.001 0.30 0.18–0.51 <0.001
HTC-HIV testing and counselling.
https://doi.org/10.1371/journal.pone.0181691.t004
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circumcised males (P <0.0001). Amongst partners eligible for VMMC, 65.9% accepted referral
for VMMC.
Discussion
In a high HIV incidence area of South Africa, HIV incidence was found to be low amongst
pregnant and postpartum women who received a community-based combination individual
and couple’s HIV prevention intervention. Previous studies have found HIV incidence
amongst nonpregnant female adolescents in the same district to be 17.2 infections/100 PY
[28]; 10.7 infections/100 PY during pregnancy (all ages) in South Africa [6]; and 16.8 infec-
tions/100 PY during pregnancy in neighbouring Swaziland [35]. A recent systematic review
and meta-analysis of HIV incidence during pregnancy/postpartum in Southern Africa indi-
cated HIV incidence of 4.8 infections/100 PY (95% CI: 3.5–6.4) [11]. Recent South African
data from a national survey estimated cumulative HIV incidence during pregnancy to be 3.3%
(95% CI: 2.8%-3.8%) [14]. The maternal HIV incidence rate measured in our study thus repre-
sents a decrease of 73%–86% compared to previously published Southern African studies.
One of South Africa’s strategic health objectives is to reduce HIV incidence by 50% by the
end of 2016 [36]. However, to decrease HIV incidence and prevalence over a 50-year time-
scale, it has recently been shown that substantial scale-up of combination HIV prevention pro-
grams will be required [37]. Community health workers have been drafted as a priority work-
force in South Africa’s approach to re-engineering primary healthcare [25]. This community-
based intervention shows promise in reducing high HIV incidence amongst pregnant and
postpartum women.
MTCT amongst women acquiring HIV during pregnancy was high, similar to previous
studies [12,13], and is due to high maternal HIV viral load and reduced transfer of protective
immunity to the child during acute maternal infection [38].
Male involvement and uptake of partner HTC in antenatal settings in sub-Saharan African
is low [39–41]. Partner HTC uptake in this intervention was considerably higher than in a pre-
vious South African trial (11%-32%) [42]. Most previous studies investigating incident HIV
infection during pregnancy/lactation did not attempt to record male partner’s HIV serostatus
[6,10,35,43,44]. One Kenyan study recorded partner’s HIV status as reported by women [9].
Our study is unusual in that it attempted to directly measure partner’s HIV serostatus; and
found that almost half of incident infections in women were associated with the main partner
being HIV-infected. It is notable that amongst woman who acquired HIV and whose partners
tested HIV-positive, partners first accepted HTC only after the woman seroconverted. The ser-
ostatus of the partner was thus initially unknown, and the couple may not have taken precau-
tions to minimize transmission. Prioritizing HTC of partners (and initiating ART if required)
as early as possible during pregnancy is thus important to detect serodiscordant couples and to
minimize transmission risk.
Circumcision does not decrease the risk of HIV transmission from HIV-infected men to
uninfected women [45]. The protective effect of partner circumcision in our study is likely an
indirect effect related to lower HIV prevalence amongst circumcised partners who had
unknown HIV status, as amongst males with known HIV status, uncircumcised males had
considerably higher HIV prevalence.
Concerns and uncertainty about the safety of tenofovir disoproxil fumarate (TDF)-based
PrEP during pregnancy and lactation have prevented large-scale PrEP implementation
amongst women of child-bearing age. Indeed, current South African public sector HIV guide-
lines consider PrEP use for commercial sex workers only [46,47], while private sector guide-
lines consider PrEP contraindicated during pregnancy and breastfeeding and do not address
A community-based combination HIV prevention intervention for pregnant and postpartum women in South Africa
PLOS ONE | https://doi.org/10.1371/journal.pone.0181691 July 27, 2017 10 / 15
the issue of PrEP for HIV-uninfected pregnant and breastfeeding women within serodiscor-
dant couples [18]. Given the efficacy of PrEP in preventing HIV acquisition amongst adherent
women (up to 75% risk reduction in heterosexual African couples) [48], and balanced with
potential concerns of the effect of PrEP on the fetus/infant, it has recently been suggested that
studies should identify subgroups of pregnant/postpartum women at high risk of acquiring
HIV, and limit provision of PrEP to these subgroups [9,49]. Notably, studies involving breast-
feeding HIV-infected women and their infants showed very low exposure to TDF from breast
milk [50,51]. Also, duration of in-utero exposure to TDF was not associated with infant early
linear growth [52]. There are few studies of TDF in HIV-uninfected women. However, data
from hepatitis B virus (HBV) mono-infected pregnant women showed foetal/infant exposure
to TDF was not associated with any adverse outcomes, and TDF reduced perinatal HBV trans-
mission [53–55]. Data from two PrEP studies in HIV-uninfected women are similarly reassur-
ing [19,56]. Given the limited available safety data, ongoing surveillance is needed, but the
benefits of PrEP use for pregnant/lactating women at high risk of HIV acquisition (and associ-
ated increased risk of MTCT) appears to far outweigh the potential risks of foetal, infant and
maternal TDF exposure [57]. Therefore, strong consideration should be given to revising
South African guidelines to include initiation and maintenance of PrEP for HIV-uninfected
women within serodiscordant couples during pregnancy and breastfeeding. Recent cost-effec-
tiveness modelling has shown that provision of PrEP to pregnant/breastfeeding women in
sub-Saharan Africa would likely be cost-effective [49].
Challenges to the program included women not always being available for home visits or
clinic groups because of work commitments; broaching issues regarding age-disparate and
concurrent sexual relationships during individual counselling; and inconsistent uptake of
HTC amongst men.
The strengths of the study include that prospective cohort data were collected that enabled
detection of incident HIV throughout pregnancy and postpartum. The routine urban setting
with high HIV incidence indicates that results would likely be generalizable to other high HIV
incidence Southern African settings. LTFU was reasonable, considering that LTFU of pregnant
women from health programs in Southern Africa may be substantial [58,59].
The study limitations include the lack of a comparison cohort who did not receive the inter-
vention to directly measure the effect of the intervention. Due to the data’s routine nature, a
relatively small number of potential predictors of HIV acquisition were available for analysis.
Although the few incident HIV infections was encouraging, low case numbers resulted in
imprecise effect measures of factors associated with incident HIV infection. Partner HIV test-
ing frequently post-dated that of the female partner due to slower uptake of male HIV testing,
thus for those partners who tested HIV-positive at initial testing, we could not distinguish
prevalent male partner HIV infection at baseline (i.e. the pregnant women’s first antenatal
clinic visit) from incident male HIV infection during the woman’s follow-up. The proportion
of referred men who received VMMC was also unavailable in the routine dataset.
In conclusion, low HIV incidence amongst pregnant and postpartum women in a high
HIV incidence setting was observed amongst women who received a community-based com-
bination HIV prevention intervention for women and couples. Incident HIV cases were highly
associated with serodiscordant couples and new HIV diagnoses in male partners. Expanded
roll-out of combination HIV prevention interventions incorporating home-based couples
HTC for pregnant women and partners in high HIV prevalence settings should be considered,
attempting early uptake of HTC amongst males and referral for VMMC or ART initiation as
indicated. Together with ART for HIV-infected partners, initiating PrEP for HIV-uninfected
pregnant and breastfeeding women within serodiscordant couples should be considered to
decrease both maternal HIV incidence and pediatric HIV. Increased frequency of HIV testing
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of pregnant women (4–6 weekly) should be considered, and further research is needed regard-
ing innovative and feasible strategies to enhance early HTC uptake for partners.
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